Clinical Impact Through AI-assisted MS Care - A Retrospective Multi-center Observational Study.

Launched by ICOMETRIX · Feb 19, 2024

Keywords

ClinConnect Summary

The RECLAIM study is looking to improve how we understand and treat Multiple Sclerosis (MS) and related conditions, such as Neuromyelitis Optica Spectrum Disorder and Clinically Isolated Syndrome. Researchers are collecting data from patients to create advanced computer models using artificial intelligence (AI). These models will help doctors better diagnose MS and predict how the disease might progress in individual patients. By analyzing this information, the study aims to develop improved tools for monitoring the disease over time.

To participate in this study, patients need to have a confirmed diagnosis of one of the conditions mentioned. They must also have given permission for their data to be used in this research. Unfortunately, those under 18 years old cannot take part. If you join the study, you can expect to contribute to important research that could lead to better care for people with MS and related disorders. This is an exciting opportunity to help shape the future of MS treatment!

Gender

ALL

Eligibility criteria

• Inclusion criteria:
• • Patients must have a confirmed diagnosis of MS, NMOSD, MOGAD, CIS or RIS.
• • Patient (or patient's legal representative) has previously signed and dated an informed consent form (ICF) for the secondary use of their data, or assent form. Alternatively, the secondary use of the patient's data is allowed following Institutional Review Board (IRB)/Ethical Committee (EC) approval in accordance with national and local subject privacy regulations.
• Exclusion criteria:
• • Patients under 18 years of age will be excluded.
• • Other unspecified reasons that, in the opinion of the Investigator or Joint Steering Committee, make the patient unsuitable for participation in the study.